Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
46.05
30.51
9.81
8.74
Share Warrants & Outstandings
Total Reserve
740.13
173.76
35.68
27.85
Shareholder's Funds
786.18
204.27
45.50
36.59
Minority Interest
26.06
27.44
0.00
0.00
Long-Term Borrowings
162.46
133.65
29.73
12.22
Secured Loans
80.78
27.95
0.00
0.00
Unsecured Loans
81.68
105.70
29.73
12.22
Deferred Tax Assets / Liabilities
-18.67
-14.96
2.10
-0.45
Other Long Term Liabilities
8.2
7.78
1.58
0.41
Long Term Trade Payables
0.00
0.00
0.00
0.00
Long Term Provisions
3.26
1.24
0.26
0.05
Total Non-Current Liabilities
155.25
127.71
33.67
12.23
Current Liabilities
Trade Payables
67.22
113.01
13.58
7.14
Other Current Liabilities
29.12
18.38
7.19
0.75
Short Term Borrowings
142.30
114.73
31.03
1.99
Short Term Provisions
2.06
1.38
0.08
0.01
Total Current Liabilities
240.70
247.50
51.88
9.88
Total Liabilities
1,208.19
606.92
131.05
58.70
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
318.78
238.34
28.17
7.60
Less: Accumulated Depreciation
27.45
12.05
2.62
1.15
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
291.33
226.29
25.55
6.45
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
44.17
17.77
8.05
0.35
Intangible assets under development
128.33
79.32
26.41
7.72
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
0.01
0.01
16.45
15.40
Long Term Loans & Advances
9.99
23.48
1.16
1.14
Other Non Current Assets
2.57
0.00
0.40
0.14
Total Non-Current Assets
485.76
356.01
79.72
31.65
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
Inventories
56.63
37.37
3.12
2.98
Sundry Debtors
123.88
112.01
22.11
19.63
Cash and Bank
385.50
13.06
0.10
3.21
Other Current Assets
124.15
69.09
17.47
0.01
Short Term Loans and Advances
32.27
19.38
8.53
1.21
Total Current Assets
722.43
250.91
51.34
27.05
Net Current Assets (Including Current Investments)
481.73
3.41
-0.55
17.17
Total Current Assets Excluding Current Investments
722.43
250.91
51.34
27.05
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
Total Assets
1,208.19
606.92
131.05
58.70
Contingent Liabilities
20.93
22.97
8.35
0.00
Total Debt
304.76
248.38
60.76
14.21
Book Value per share (adjusted)
170.72
66.95
46.36
41.86
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 22.70% vs 308.79% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 5.40% vs 392.41% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 37.47% vs 626.37% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -99.94% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 187.92% vs 388.72% in Mar 2024
Compare Balance Sheet Results of Senores Pharma.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
46.05
14.39
31.66
220.01%
Share Warrants & Outstandings
Total Reserve
740.13
57.18
682.95
1,194.39%
Shareholder's Funds
786.18
72.52
713.66
984.09%
Minority Interest
26.06
0
26.06
0.00%
Long-Term Borrowings
162.46
84.88
77.58
91.40%
Secured Loans
80.78
75.51
5.27
6.98%
Unsecured Loans
81.68
9.38
72.30
770.79%
Deferred Tax Assets / Liabilities
-18.67
-2.97
-15.70
-528.62%
Other Long Term Liabilities
8.20
0
8.20
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
3.26
0
3.26
0.00%
Total Non-Current Liabilities
155.25
81.92
73.33
89.51%
Current Liabilities
Trade Payables
67.22
30.93
36.29
117.33%
Other Current Liabilities
29.12
6.59
22.53
341.88%
Short Term Borrowings
142.30
0
142.30
0.00%
Short Term Provisions
2.06
4.97
-2.91
-58.55%
Total Current Liabilities
240.70
42.49
198.21
466.49%
Total Liabilities
1,208.19
196.92
1,011.27
513.54%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
318.78
93.47
225.31
241.05%
Less: Accumulated Depreciation
27.45
54.88
-27.43
-49.98%
Less : Impairment of Assets
0.00
12.47
-12.47
-100.00%
Net Block
291.33
26.12
265.21
1,015.35%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
44.17
11.97
32.20
269.01%
Intangible assets under development
128.33
0
128.33
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.01
89.84
-89.83
-99.99%
Long Term Loans & Advances
9.99
0
9.99
0.00%
Other Non Current Assets
2.57
0
2.57
0.00%
Total Non-Current Assets
485.76
127.93
357.83
279.71%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
56.63
19.27
37.36
193.88%
Sundry Debtors
123.88
24.42
99.46
407.29%
Cash and Bank
385.50
8.19
377.31
4,606.96%
Other Current Assets
124.15
0.67
123.48
18,429.85%
Short Term Loans and Advances
32.27
16.43
15.84
96.41%
Total Current Assets
722.43
68.99
653.44
947.15%
Net Current Assets (Including Current Investments)
481.73
26.50
455.23
1,717.85%
Total Current Assets Excluding Current Investments
722.43
68.99
653.44
947.15%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
1,208.19
196.92
1,011.27
513.54%
Contingent Liabilities
20.93
139.24
-118.31
-84.97%
Total Debt
304.76
84.88
219.88
259.05%
Book Value per share (adjusted)
170.72
49.79
120.93
242.88%
Annual - Borrowings
Borrowings 304.76 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 22.70% vs 308.79% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.40% vs 392.41% in Mar 2024
Annual - Fixed Assets
Fixed Assets 335.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.47% vs 626.37% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -99.94% in Mar 2024
Annual - Current Assets
Current Assets 722.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 187.92% vs 388.72% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
